Barclays PLC Takes Position in Kewaunee Scientific Co. (NASDAQ:KEQU)

Barclays PLC purchased a new position in Kewaunee Scientific Co. (NASDAQ:KEQU) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,621 shares of the technology company’s stock, valued at approximately $121,000.

A number of other hedge funds also recently bought and sold shares of KEQU. Dimensional Fund Advisors LP grew its stake in shares of Kewaunee Scientific by 3.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after buying an additional 6,132 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Kewaunee Scientific by 13.4% in the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after acquiring an additional 10,580 shares during the last quarter. Ritholtz Wealth Management lifted its holdings in shares of Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after acquiring an additional 2,156 shares during the last quarter. De Lisle Partners LLP grew its position in Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after acquiring an additional 11,511 shares in the last quarter. Finally, State Street Corp bought a new stake in Kewaunee Scientific during the third quarter worth approximately $266,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Insider Buying and Selling at Kewaunee Scientific

In other news, VP Elizabeth D. Phillips sold 1,850 shares of Kewaunee Scientific stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the sale, the vice president now directly owns 13,591 shares in the company, valued at approximately $736,224.47. This trade represents a 11.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Donald T. Gardner III sold 2,049 shares of the business’s stock in a transaction on Tuesday, December 24th. The shares were sold at an average price of $58.19, for a total transaction of $119,231.31. Following the sale, the chief financial officer now directly owns 22,615 shares of the company’s stock, valued at $1,315,966.85. This represents a 8.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,994 shares of company stock worth $729,430 over the last 90 days. Company insiders own 14.20% of the company’s stock.

Kewaunee Scientific Stock Down 0.1 %

NASDAQ KEQU opened at $60.97 on Friday. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $67.20. The firm has a market capitalization of $175.11 million, a price-to-earnings ratio of 9.66 and a beta of 0.72. The company has a fifty day moving average of $52.03 and a two-hundred day moving average of $45.82.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings results on Wednesday, December 11th. The technology company reported $1.41 EPS for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Kewaunee Scientific Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.